Recurring concern
Unsafe intravenous fluid management
- Reports that mention this concern
- 11
- Times this concern has been raised
- 14
- Stated actions linked to this concern
- 18
What this concern includes
Includes failures of controls dedicated to intravenous fluid management, including assessment before prescribing, dose or bolus selection, monitoring of relevant clinical results, reassessment after administration and escalation when treatment risks or response require review.
What is not included
- Excludes failures involving oral or enteral fluids where intravenous fluid therapy is not materially involved.
- Excludes generic monitoring, prescribing or clinical-review deficiencies that are not specifically tied to intravenous fluid management.
- Excludes failures limited to cannula equipment, infusion delivery or fluid-balance recording unless they directly concern the safe management of intravenous fluid therapy.
- Excludes treatment decisions concerning electrolytes or other conditions where intravenous fluid management is not the identified unsafe process.
Trends
Reports over time
Reports mentioning this concern, over time
Reports about this concern issued each year.
* 2026 is projected from reports observed to 7 Sep 2026.
Most frequent recipients
Most frequent recipients
Reports about this concern sent to each recipient.
Reports and published responses 11 reports
See individual reports that have raised this concern, and the actions taken in response
-
Concerns raised1
Failure to appropriately assess and manage a non-running saline infusion
This report raised 8 other concerns. They are not shown here because they do not form part of this recurring concern.
No linked response statementsNo respondent-stated action or position is linked to these concerns in the published data.
Actions and positions describe what organisations say in published responses. Implementation is not independently verified.
Data last updated 7 September 2026